Working… Menu
Trial record 47 of 882 for:    "Reticulum Cell Sarcoma"

ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00140660
Recruitment Status : Terminated (Low acrual)
First Posted : September 1, 2005
Last Update Posted : March 13, 2017
Information provided by (Responsible Party):
Lymphoma Study Association

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2008
Actual Study Completion Date : April 2012
Publications automatically indexed to this study by Identifier (NCT Number):